lipid-lowering


Related to lipid-lowering: Antihyperlipidemic, Hypolipidemic agent
a.1.(Med.) Serving to reduce the concentration of lipid, such as cholesterol, in the blood; - of medications, such as Mevinolin, that are used especially to reduce blood cholesterol, as a preventive measure against heart disease.
References in periodicals archive ?
A total of 27% reported using lipid-lowering medications at baseline; roughly half used statins and half used fibrates.
Blood lipid-lowering drugs performs better than the overall drug market and cardiovascular system drugs.
After measurement of blood lipid levels and initiation of lipid-lowering therapy, the Work Group found little evidence to justify ongoing assessment of dyslipidemia.
LOJUXTA is indicated as an adjunct to a low-fat diet and other lipid-lowering medicinal products with or without low density lipoprotein (LDL) apheresis in adult patients with homozygous familial hypercholesterolemia (HoFH).
Depending on the results of the blood cholesterol tests, your doctor may advise you to make diet and lifestyle changes, may prescribe lipid-lowering drugs, or in some cases take both of these measures.
NEW ORLEANS -- In major clinical trials of lipid-lowering agents, the mortality benefit derived from medical therapy persists long after the studies end, according to a meta-analysis presented at the meeting.
Higher plasma levels of HDL cholesterol were associated with a decreased risk of both probable and possible Alzheimer's disease, even after adjusting for vascular risk factors and lipid-lowering treatments.
In that well-designed study, they indicated that alternate-day dosing of atorvastatin causes a significant lipid-lowering and antiinflammatory effects similar to that of daily administration and it may provide some cost savings (1).
In the present study, the black tea major component theaflavins were assessed for their hepatic lipid-lowering potential when administered in fatty acid overload conditions both in cell culture and in an animal experimental model.
The latest findings from the "Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial" or ALLHAT, sponsored by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health, are published in the January 28 issue of "Archives of Internal Medicine"
A case of a patient on multiple lipid-lowering medications, including high-dose atorvastatin whose LDL cholesterol improved significantly after discontinuation of phenytoin is presented, and a review of the literature for similar cases is discussed.
Researchers wanted to investigate this further so they recruited 20 subjects to conduct a single-blind, randomized study to assess the effect of plant stanols in margarines, combined with a lipid-lowering dietary intervention, in patients already on lipid-lowering medications at maximal doses not reaching their target lipid levels.